My Portfolio

Novavax Inc NVAX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 2:24 PM EDT

10.28

+0.07 (+0.69%)

Volume

1,893,453

52 week range

6.13 - 11.97

Open10.14
Day High10.28
Day Low9.94
Prev Close10.21
52 Week High11.97
52 Week High Date02/26/26
52 Week Low6.13
52 Week Low Date06/23/25

Latest On Novavax Inc

Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatileMay 11, 2026CNBC.com
FDA vaccine head will step down in April after string of controversial decisionsMarch 6, 2026CNBC.com
Friday's biggest analyst calls the day: Nvidia, Intel, Beyond Meat, AmazonOctober 24, 2025CNBC.com
Pfizer, Moderna fall on report Trump officials to link child deaths to Covid shotsSeptember 12, 2025CNBC.com
The vaccine and public health debate at the center of CDC upheaval, explainedAugust 28, 2025CNBC.com
Why pharma stocks are shrugging off RFK’s new Covid vaccine restrictions August 28, 2025CNBC.com
FDA approves new Covid shots with limits on who can get themAugust 27, 2025CNBC.com
FDA may pull authorization of Pfizer's Covid vaccine for kids under 5, company saysAugust 12, 2025CNBC.com
Moderna's flu vaccine shows positive trial results, paving way for combo shotJune 30, 2025CNBC.com

Key Stats

Market Cap1.69B
Shares Out164.44M
10 Day Average Volume5.80M
Dividend-
Dividend Yield-
Beta2.41

Latest On Novavax Inc

Hantavirus cases spark brief surge in pharma and biotech stocks — here’s why trading is so volatileMay 11, 2026CNBC.com
FDA vaccine head will step down in April after string of controversial decisionsMarch 6, 2026CNBC.com
Friday's biggest analyst calls the day: Nvidia, Intel, Beyond Meat, AmazonOctober 24, 2025CNBC.com
Pfizer, Moderna fall on report Trump officials to link child deaths to Covid shotsSeptember 12, 2025CNBC.com
The vaccine and public health debate at the center of CDC upheaval, explainedAugust 28, 2025CNBC.com
Why pharma stocks are shrugging off RFK’s new Covid vaccine restrictions August 28, 2025CNBC.com
FDA approves new Covid shots with limits on who can get themAugust 27, 2025CNBC.com
FDA may pull authorization of Pfizer's Covid vaccine for kids under 5, company saysAugust 12, 2025CNBC.com
Moderna's flu vaccine shows positive trial results, paving way for combo shotJune 30, 2025CNBC.com

KEY STATS

Open10.14
Day High10.28
Day Low9.94
Prev Close10.21
52 Week High11.97
52 Week High Date02/26/26
52 Week Low6.13
52 Week Low Date06/23/25
Market Cap1.69B
Shares Out164.44M
10 Day Average Volume5.80M
Dividend-
Dividend Yield-
Beta2.41

RATIOS/PROFITABILITY

EPS (TTM)-0.58
P/E (TTM)-17.77
Fwd P/E (NTM)-13.33
EBITDA (TTM)59.532M
ROE (TTM)-898.20%
Revenue (TTM)596.338M
Gross Margin (TTM)84.97%
Net Margin (TTM)-14.73%
Debt To Equity (MRQ)-203.82%

EVENTS

Earnings Date08/04/2026(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

FDA issues draft guidance to help accelerated cell, gene therapies for patientsJune 2, 2026TipRanks
Novavax Updates Pediatric COVID-19 Vaccine Trial: What Investors Should WatchMay 22, 2026TipRanks
Trump confirms Kyle Diamantas to be acting head of FDAMay 12, 2026TipRanks
Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT saysMay 11, 2026TipRanks
Unusually active option classes on open May 11thMay 11, 2026TipRanks

Profile

Novavax, Inc. is a biotechnology company. It is focused on addressing global health challenges through its vaccines and its proven technology platform, including protein-based nanoparticles and its Matrix-M adjuvant. Matrix-M can be used to create vaccines for a variety of diseases to help tackle some of the pressing health challenges. Its proprietary Matrix-M adjuvant, when added to vaccines, has been shown to help induce a stronger and longer-lasting immune response. Its...

Margaret McGlynn

Independent Chairman of the Board

John Jacobs

President, Chief Executive Officer, Director

James Kelly

Chief Financial Officer, Executive Vice President, Treasurer

Mark Casey

Executive Vice President, Chief Legal Officer, Corporate Secretary

Robert Walker M.D.

Executive Vice President, Head - Research & Development

Address

21 Firstfield Rd

Gaithersburg, MD

20878

United States

https://www.novavax.com/?locale=US